Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARL | Q9H300 | 2/20 | 0.50 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.48 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.48 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.48 |
| ▸ | HTR6 | P50406 | 1/20 | 0.48 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | CA1 | P00915 | 3/20 | 0.44 |
| ▸ | CA2 | P00918 | 3/20 | 0.44 |
| ▸ | CA9 | Q16790 | 3/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA3 | P07451 | 1/20 | 0.44 |
| ▸ | CA4 | P22748 | 1/20 | 0.44 |
| ▸ | CA6 | P23280 | 1/20 | 0.44 |
| ▸ | CA5A | P35218 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.44 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30011527 | 0.93 | ALDH1A1 (0.50) | PARLDUSP3PTPN5PTPN11HTR6 | |
| SCHEMBL14778910 | 0.91 | PARL (0.47) | PARLDUSP3PTPN5PTPN11HTR6 | |
| SCHEMBL5945104 | 0.91 | PARL (0.47) | PARLHTR6PSIP1ALDH1A1TDP1 | |
| SCHEMBL3911054 | 0.89 | MAPK1 (0.50) | PARLDUSP3PTPN5PTPN11HTR6 | |
| SCHEMBL14779172 | 0.89 | PARL (0.46) | PARLHTR6PSIP1ALDH1A1TDP1 | |
| SCHEMBL14779590 | 0.89 | PARL (0.46) | PARLHTR6PSIP1ALDH1A1TDP1 | |
| SCHEMBL8154425 | 0.89 | PARL (0.46) | PARLDUSP3PTPN5PTPN11HTR6 | |
| SCHEMBL1607966 | 0.88 | KCNA3 (0.50) | ALDH1A1CA1CA2CA9CA12 | |
| SCHEMBL778545 | 0.87 | PSIP1 (0.50) | PARLHTR6PSIP1ALDH1A1TDP1 | |
| SCHEMBL2762091 | 0.87 | PARL (0.44) | PARLDUSP3PTPN5PTPN11HTR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1994008981-A1 | PREPARATION OF ORGANIC MACROCYCLIC COMPOUNDS | UNILEVER PLC (GB) | 1994-04-28 | — | — | WO | claimed |
| EP-4707272-A1 | METHOD OF PREPARING BENZENESULFONYL COMPOUND, AND ELECTROLYTE FOR A SECONDARY BATTERY OR A LITHIUM-ION BATTERY COMPRISING THE BENZENESULFONYL COMPOUND | SK Innovation Co., Ltd. (KR) | 2026-03-11 | — | — | EP | disclosed |
| US-20260062380-A1 | METHOD OF PREPARING BENZENESULFONYL COMPOUND | SK INNOVATION CO LTD (KR) | 2026-03-05 | — | — | US | disclosed |
| EP-2969201-B1 | NON-PHTHALATE COMPOUNDS AS ELECTRON DONORS FOR POLYOLEFIN CATALYSTS | FORMOSA PLASTICS CORP USA (US) | 2022-05-04 | — | — | EP | disclosed |
| US-11114693-B2 | Electrolytic solution for nonaqueous electrolytic solution secondary batteries and nonaqueous electrolytic solution secondary battery | CENTRAL GLASS COMPANY, LTD. (JP) | 2021-09-07 | — | — | US | disclosed |
| EP-3333962-B1 | ELECTROLYTIC SOLUTION FOR NONAQUEOUS ELECTROLYTIC SOLUTION SECONDARY BATTERIES AND NONAQUEOUS ELECTROLYTIC SOLUTION SECONDARY BATTERY | CENTRAL GLASS CO LTD (JP) | 2020-10-07 | — | — | EP | disclosed |
| US-20200212485-A1 | Non-Aqueous Electrolyte Solution and Non-Aqueous Electrolyte Battery in Which Same Is Used | CENTRAL GLASS COMPANY, LIMITED (JP) | 2020-07-02 | — | — | US | disclosed |
| EP-2827433-B1 | SECONDARY BATTERY ELECTROLYTE AND SECONDARY BATTERY USING SAME | ENVISION AESC ENERGY DEVICES LTD (JP) | 2019-09-25 | — | — | EP | disclosed |
| EP-3333962-A1 | NON-AQUEOUS ELECTROLYTE SOLUTION AND NON-AQUEOUS ELECTROLYTE BATTERY IN WHICH SAME IS USED | Central Glass Co., Ltd. (JP) | 2018-06-13 | — | — | EP | disclosed |
| US-9790291-B2 | Non-phthalate compounds as electron donors for polyolefin catalysts | FORMOSA PLASTICS CORPORATION, USA (US) | 2017-10-17 | — | — | US | disclosed |
| EP-1612231-B1 | Inhibition of catalyst-active impurities in polycarbonate transesterification process | BAYER MATERIALSCIENCE AG (DE) | 2010-03-24 | — | — | EP | disclosed |
| US-20090117314-A1 | PROCESS FOR THE PREPARATION OF POLYCARBONATE BY THE MELT TRANSESTERIFICATION METHOD | BAYER MATERIALSCIENCE AG (DE) | 2009-05-07 | — | — | US | disclosed |
| US-20080319156-A1 | Process For The Preparation Of Polycarbonate By The Melt Transesterification Process | BAYER MATERIALSCIENCE AG (DE) | 2008-12-25 | — | — | US | disclosed |
| US-7250483-B2 | Inhibition of catalytically active impurities in polycarbonate by the melt transesterification process | BAYER MATERIALSCIENCE AG (DE) | 2007-07-31 | — | — | US | disclosed |
| US-7250483-B2 | Inhibition of catalytically active impurities in polycarbonate by the melt transesterification process | BAYER MATERIALSCIENCE AG (DE) | 2007-07-31 | — | — | US | disclosed |
| EP-0602254-B1 | POLYMERIZABLE MONOMER, POLYMER THEREOF, AND PROCESS FOR PRODUCING THE SAME | OTSUKA KAGAKU KK (JP) | 1997-01-02 | — | — | EP | disclosed |
| US-5326861-A | Cyclization | LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) | 1994-07-05 | — | — | US | disclosed |
| EP-0602254-A1 | POLYMERIZABLE MONOMER, POLYMER THEREOF, AND PROCESS FOR PRODUCING THE SAME | OTSUKA KAGAKU KABUSHIKI KAISHA (JP) | 1994-06-22 | — | — | EP | disclosed |
| WO-1994008981-A1 | PREPARATION OF ORGANIC MACROCYCLIC COMPOUNDS | UNILEVER PLC (GB) | 1994-04-28 | — | — | WO | disclosed |
| US-4824608-A | ALKYLATING 16,17-DIHYDROXYVIOLANTHRENE-5,10-DIONE IN TERTIARY ALIPHATIC OR CYCLOALIPHATIC AMINE AS SOLVENT | BASF AKTIENGESELLSCHAFT (DE) | 1989-04-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11114693-B2 | Electrolytic solution for nonaqueous electrolytic solution secondary batteries and nonaqueous electrolytic solution secondary battery | ESPL1, TST, PEF1 | PARL 2775/4885DUSP3 2130/4885PTPN5 1399/4885 |
| US-20200212485-A1 | Non-Aqueous Electrolyte Solution and Non-Aqueous Electrolyte Battery in Which Same Is Used | SLC9A1, TST, CA1 | PARL 3844/4885DUSP3 1551/4885PTPN5 235/4885 |
| US-20260062380-A1 | METHOD OF PREPARING BENZENESULFONYL COMPOUND | ADH1A, ADH1C, CYP2E1 | PARL 3460/4885DUSP3 3122/4885PTPN5 2836/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.